Capital Fund Management (CFM)’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-158,647
Closed -$1.31M 1978
2023
Q2
$1.31M Sell
158,647
-80,819
-34% -$704K 0.01% 1327
2023
Q1
$1.74M Sell
239,466
-142,882
-37% -$1.27M 0.01% 1102
2022
Q4
$3.39M Sell
382,348
-112,502
-23% -$1.23M 0.02% 767
2022
Q3
$6.06M Buy
494,850
+116,188
+31% +$1.81M 0.05% 484
2022
Q2
$4.48M Buy
378,662
+11,154
+3% +$149K 0.04% 539
2022
Q1
$6.99M Buy
367,508
+115,802
+46% +$2.15M 0.06% 460
2021
Q4
$6.68M Buy
251,706
+237,492
+1,671% +$8.17M 0.05% 530
2021
Q3
$584K Sell
14,214
-1,977
-12% -$108K ﹤0.01% 1335
2021
Q2
$917K Buy
+16,191
New +$598K 0.01% 1178
2020
Q4
Sell
-32,166
Closed -$903K 1345
2020
Q3
$903K Buy
+32,166
New +$1.05M 0.01% 903
2020
Q1
Sell
-13,087
Closed -$388K 1662
2019
Q4
$388K Buy
+13,087
New +$327K ﹤0.01% 1500
2019
Q1
Sell
-68,912
Closed -$1.57M 1762
2018
Q4
$1.57M Buy
68,912
+43,240
+168% +$1.18M 0.01% 937
2018
Q3
$817K Buy
+25,672
New +$830K ﹤0.01% 1440

Other funds holding EDIT

Capital Fund Management (CFM)'s EDIT Position: Q3 2023 in Review

Capital Fund Management (CFM) sold out of Editas Medicine (EDIT) in Q3 2023, closing a stake of 158,647 shares — an estimated $1.31M sold.

Capital Fund Management (CFM) first reported a position in EDIT in Q3 2018 and held it in 13 quarters. The position peaked at $6.99M in Q1 2022. 220 funds tracked by Wall St. Rank hold EDIT as of Q3 2023.

  • Capital Fund Management (CFM) reported no remaining Editas Medicine position as of Q3 2023 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 158,647 Editas Medicine shares in Q3 2023, an estimated $1.31M.
  • Capital Fund Management (CFM) first reported a position in Editas Medicine in Q3 2018 and held it in 13 quarters.
  • Capital Fund Management (CFM)'s Editas Medicine position peaked at $6.99M in Q1 2022.
  • 220 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2023.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2023, filed 14 Nov 2023.